ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1308

MRI of Bilateral Hands Prevents Clinicians from Failing to Detect Joint Damage of Patients with Rheumatoid Arthritis Compared to Scanning Unilateral Hand

Yuji Kukida1, Akiko Kasahara1, Takahiro Seno1, Takuya Inoue1, Risa Sagawa1, Takashi Kida1, Amane Nakabayashi1, Hidetake Nagahara1, Ken Murakami1, Satoshi Morita2, Hirotoshi Ito3, Masataka Kohno1 and Yutaka Kawahito1, 1Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan, 2Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan, 3Department of Radiology, Kajiicho Medical Imaging Center, Kyoto, Japan

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: MRI and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Imaging of Rheumatic Diseases - Poster II: XR/CT/PET/MRI

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Almost all previous clinical trials investigating the drug efficacy in patients with rheumatoid arthritis (RA) on the outcome of MRI were based on scans of a unilateral hand (unilateral approach). The aim of this study is to identify the usefulness of MRI scanning bilateral hands (bilateral approach) of patients with RA in clinical practice.

Methods: Thirty-five RA patients participated in this prospective study and received intravenous abatacept treatment for 12 months. MRI of bilateral hands was performed at baseline and 12 months. MRI images were scored for synovitis, osteitis and bone erosion according to the Rheumatoid Arthritis MRI Scoring System (OMERACT-RAMRIS). Score of unilateral hand was defined as score of hand with higher synovitis score. The smallest detectable changes (SDCs) in MRI scores were calculated to estimate the measurement error and a definite change of MRI score (progression or regression) was defined as a change in the score greater than the SDC cut-off. First, we compared MRI scores between hands at baseline and explored imbalances in the imaging scores for each hand. Next, we compared the treatment results obtained by MRI with the “bilateral approach” to those obtained by MRI with the “unilateral approach”.

Results: Imbalances in the synovitis, osteitis, and erosion scores were identified at baseline in 14%, 51%, and 40% of enrolled patients, respectively. We also found that the hand with the higher synovitis score was different from the hand with the higher osteitis score in 11% of patients and from the hand with the higher erosion score in 37% of patients. After 12-month treatment, higher number of patients with progressive synovitis and osteitis scores was detected in the “bilateral approach” than was detected in the “unilateral approach” (synovitis; one case in the “unilateral approach” /four cases in the “bilateral approach”, osteitis; none case /one case, respectively). No significant difference between two approaches was observed. The number of patients with progressive erosion scores was same (six cases in both approaches).

Conclusion: Our data revealed that high prevalence of imbalances in MRI scores between hands and that MRI by the “bilateral approach” revealed higher number of patients who showed progressions in synovitis and osteitis scores compared to the “unilateral approach”. These results imply that MRI of unilateral hands could make clinicians fail to detect joint damage of the other hand and that scanning bilateral hands provides more reliable information about joint damage of patients with RA in clinical practice.


Disclosure: Y. Kukida, None; A. Kasahara, None; T. Seno, None; T. Inoue, None; R. Sagawa, None; T. Kida, None; A. Nakabayashi, None; H. Nagahara, None; K. Murakami, None; S. Morita, None; H. Ito, None; M. Kohno, None; Y. Kawahito, None.

To cite this abstract in AMA style:

Kukida Y, Kasahara A, Seno T, Inoue T, Sagawa R, Kida T, Nakabayashi A, Nagahara H, Murakami K, Morita S, Ito H, Kohno M, Kawahito Y. MRI of Bilateral Hands Prevents Clinicians from Failing to Detect Joint Damage of Patients with Rheumatoid Arthritis Compared to Scanning Unilateral Hand [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/mri-of-bilateral-hands-prevents-clinicians-from-failing-to-detect-joint-damage-of-patients-with-rheumatoid-arthritis-compared-to-scanning-unilateral-hand/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mri-of-bilateral-hands-prevents-clinicians-from-failing-to-detect-joint-damage-of-patients-with-rheumatoid-arthritis-compared-to-scanning-unilateral-hand/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology